Genoskin
PrivateLast Round
Series A
Sep 16, 2025
Total Funding Raised
$10.34M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Genoskin is a biotechnology company that provides ready-to-use, live human skin models for pharmaceutical, cosmetic, and chemical product testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genoskin Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Genoskin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 16, 2025 | ||||
| Debt | Sep 16, 2025 | ||||
| Grant | Oct 28, 2020 | ||||
| Grant | Aug 29, 2019 | ||||
| Grant | Mar 7, 2018 | ||||
Early Funding | Aug 29, 2017 |
Key People
Founding team and executive leadership
Genoskin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GSO Innovation | Series A |
| Bpifrance | Grant, Debt |
| European Regional Development Fund | Grant |
| Finorpa | Series A |
| Région Occitanie | Grant |
| CA Toulouse 31 Initiatives | Series A |
| Caisse d'Epargne Midi-Pyrénées | Series A, Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 27, 2026
Fabrice Bouteille appointed to strengthen governance.
- Sep 16, 2025
$9M round completed.
Genoskin Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Genoskin's valuation, stock price, and market status.